Tonix Publishes Mpox Study Supporting TNX-801 Vaccine
BERKELEY HEIGHTS, N.J., July 15, 2026 Tonix Pharmaceuticals announced the publication of new preclinical research in the Journal of...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
BERKELEY HEIGHTS, N.J., July 15, 2026 Tonix Pharmaceuticals announced the publication of new preclinical research in the Journal of...
COPENHAGEN, DENMARK — February 18, 2026 Bavarian Nordic has secured a USD 22.5 million vaccine supply contract from the...
